Government of Saskatchewan Expands Public Coverage for Dexcom Continuous Glucose Monitoring Systems
Dexcom (NASDAQ: DXCM) announces expanded public coverage for its continuous glucose monitoring (CGM) systems in Saskatchewan, Canada. The government's new coverage now includes young adults aged 18-25 and seniors over 65 who use any type of insulin, adding to existing coverage for ages 2-18.
The expansion, part of Budget 2025, will benefit nearly 10,000 individuals living with diabetes in the province. Dexcom's G7 and G6 CGM systems feature a predictive Urgent Low Soon alert that warns users up to 20 minutes before severe hypoglycemic events, helping prevent dangerous blood sugar levels below 3.1 mmol/L.
The systems integrate with various insulin pumps and digital health apps, including the Dexcom Follow app for remote monitoring by family members. This coverage expansion represents a significant advancement in diabetes care accessibility in Saskatchewan.
Dexcom (NASDAQ: DXCM) annuncia un ampliamento della copertura pubblica per i suoi sistemi di monitoraggio continuo della glicemia (CGM) in Saskatchewan, Canada. La nuova copertura del governo include ora giovani adulti di età compresa tra 18 e 25 anni e anziani over 65 che utilizzano qualsiasi tipo di insulina, aggiungendosi alla copertura esistente per le fasce d'età 2-18.
L'espansione, parte del Bilancio 2025, beneficerà quasi 10.000 individui affetti da diabete nella provincia. I sistemi CGM G7 e G6 di Dexcom dispongono di un avviso predittivo di bassa glicemia imminente che avverte gli utenti fino a 20 minuti prima di eventi ipoglicemici gravi, contribuendo a prevenire livelli pericolosi di zucchero nel sangue al di sotto di 3.1 mmol/L.
I sistemi si integrano con vari pump per insulina e app di salute digitale, inclusa l'app Dexcom Follow per il monitoraggio remoto da parte dei familiari. Questa espansione della copertura rappresenta un significativo avanzamento nell'accessibilità alle cure per il diabete in Saskatchewan.
Dexcom (NASDAQ: DXCM) anuncia una ampliación de la cobertura pública para sus sistemas de monitoreo continuo de glucosa (CGM) en Saskatchewan, Canadá. La nueva cobertura del gobierno ahora incluye a jóvenes adultos de 18 a 25 años y a personas mayores de 65 que utilizan cualquier tipo de insulina, sumándose a la cobertura existente para las edades de 2 a 18 años.
La expansión, parte del Presupuesto 2025, beneficiará a casi 10,000 individuos que viven con diabetes en la provincia. Los sistemas CGM G7 y G6 de Dexcom cuentan con una alerta predictiva de bajo nivel de glucosa inminente que advierte a los usuarios hasta 20 minutos antes de eventos hipoglucémicos severos, ayudando a prevenir niveles peligrosos de azúcar en sangre por debajo de 3.1 mmol/L.
Los sistemas se integran con varias bombas de insulina y aplicaciones de salud digital, incluida la aplicación Dexcom Follow para el monitoreo remoto por parte de familiares. Esta ampliación de la cobertura representa un avance significativo en la accesibilidad a la atención del diabetes en Saskatchewan.
Dexcom (NASDAQ: DXCM)은 캐나다 사스카추완에서 지속적인 혈당 모니터링(CGM) 시스템에 대한 공공 보장을 확대한다고 발표했습니다. 정부의 새로운 보장은 이제 18세에서 25세 사이의 청년과 65세 이상의 노인을 포함하며, 이는 2세에서 18세까지의 기존 보장에 추가됩니다.
2025년 예산의 일환으로 진행되는 이번 확장은 주에서 당뇨병을 앓고 있는 거의 10,000명에게 혜택을 줄 것입니다. Dexcom의 G7 및 G6 CGM 시스템은 심각한 저혈당 사건이 발생하기 최대 20분 전에 사용자에게 경고하는 예측 저혈당 경고 기능을 갖추고 있어, 3.1 mmol/L 이하의 위험한 혈당 수치를 예방하는 데 도움을 줍니다.
이 시스템은 다양한 인슐린 펌프 및 디지털 건강 앱과 통합되며, 가족이 원격으로 모니터링할 수 있도록 하는 Dexcom Follow 앱이 포함됩니다. 이번 보장 확대는 사스카추완에서 당뇨병 치료 접근성을 크게 향상시키는 것을 의미합니다.
Dexcom (NASDAQ: DXCM) annonce une extension de la couverture publique pour ses systèmes de surveillance continue de la glycémie (CGM) en Saskatchewan, au Canada. La nouvelle couverture du gouvernement inclut désormais les jeunes adultes âgés de 18 à 25 ans et les seniors de plus de 65 ans utilisant tout type d'insuline, s'ajoutant à la couverture existante pour les âges de 2 à 18 ans.
Cette extension, faisant partie du Budget 2025, bénéficiera à près de 10 000 individus vivant avec le diabète dans la province. Les systèmes CGM G7 et G6 de Dexcom disposent d'une alerte prédictive d'hypoglycémie imminente qui avertit les utilisateurs jusqu'à 20 minutes avant des événements hypoglycémiques graves, aidant ainsi à prévenir des niveaux de sucre dans le sang dangereux inférieurs à 3,1 mmol/L.
Les systèmes s'intègrent à diverses pompes à insuline et applications de santé numérique, y compris l'application Dexcom Follow pour le suivi à distance par les membres de la famille. Cette extension de la couverture représente une avancée significative dans l'accessibilité des soins du diabète en Saskatchewan.
Dexcom (NASDAQ: DXCM) kündigt eine erweiterte öffentliche Deckung für seine kontinuierlichen Glukoseüberwachungssysteme (CGM) in Saskatchewan, Kanada, an. Die neue Deckung der Regierung umfasst jetzt junge Erwachsene im Alter von 18 bis 25 Jahren und Senioren über 65, die irgendeine Art von Insulin verwenden, und ergänzt die bestehende Deckung für die Altersgruppe von 2 bis 18 Jahren.
Die Erweiterung, Teil des Haushalts 2025, wird fast 10.000 Personen mit Diabetes in der Provinz zugutekommen. Die CGM-Systeme G7 und G6 von Dexcom verfügen über eine prädiktive Warnung vor akutem niedrigem Blutzucker, die Benutzer bis zu 20 Minuten vor schweren hypoglykämischen Ereignissen warnt und hilft, gefährliche Blutzuckerwerte unter 3,1 mmol/L zu verhindern.
Die Systeme integrieren sich mit verschiedenen Insulinpumpen und digitalen Gesundheits-Apps, einschließlich der Dexcom Follow-App für die Fernüberwachung durch Familienmitglieder. Diese Erweiterung der Deckung stellt einen bedeutenden Fortschritt in der Zugänglichkeit der Diabetesversorgung in Saskatchewan dar.
- Significant market expansion through public coverage of new age groups in Saskatchewan
- Coverage applies to all insulin users, broadening the potential customer base
- Integration with multiple insulin pumps and digital health apps increases product ecosystem value
- Coverage to specific age groups (2-18, 18-25, and 65+), excluding middle-aged adults
Insights
Saskatchewan's expansion of public coverage for Dexcom CGM systems represents a significant policy shift in diabetes care accessibility. The inclusion of adults 18-25 and seniors 65+ who use any type of insulin establishes a more comprehensive coverage framework than typically seen in many jurisdictions.
What makes this policy particularly notable is its inclusive approach to insulin users. Many coverage policies restrict CGM access to specific insulin delivery methods or diabetes types, but Saskatchewan's model acknowledges that glycemic management challenges exist across all insulin-dependent populations.
This coverage decision creates a potential template for other Canadian provinces and territories considering CGM reimbursement expansions. Provincial health policies often influence each other, and Saskatchewan's approach may accelerate adoption of similar inclusive coverage frameworks elsewhere.
The immediate implementation timing (effective immediately) demonstrates strong governmental commitment to diabetes technology access. For the estimated 10,000 newly eligible individuals in Saskatchewan, this removes significant financial barriers to technology that provides substantial clinical benefits, particularly the predictive hypoglycemia alerts that can prevent dangerous low blood glucose events.
This coverage expansion establishes a meaningful new revenue channel for Dexcom in Saskatchewan. The addition of two key demographic segments (18-25 and 65+) to the existing pediatric coverage creates a comprehensive reimbursement framework across high-need populations.
The business model implications are particularly favorable. CGM systems generate both initial hardware sales and consistent recurring revenue through sensors that require regular replacement. Each new covered patient represents significant lifetime value through this razor/razor-blade model.
While Saskatchewan represents just one province, the revenue impact compounds through three mechanisms: 1) Immediate access to ~10,000 potential new users in Saskatchewan; 2) The precedent effect potentially accelerating similar coverage decisions across other Canadian provinces; and 3) The inclusive "any insulin user" criteria establishing a favorable reimbursement template.
Dexcom's ecosystem strategy is also reinforced in the announcement, highlighting integration with insulin pumps and companion applications. These connected health solutions create ecosystem lock-in that enhances customer retention and potential upsell opportunities.
This development strengthens Dexcom's competitive positioning in the Canadian diabetes technology market and supports the company's strategy of expanding public reimbursement channels internationally to supplement its established market presence.
Eligible residents living with diabetes in
As part of the provincial government’s recent Budget 2025 announcement, Dexcom G7 and Dexcom G6 CGM systems are now publicly covered for residents living with diabetes age 18-25 and those over 65 who use any type of insulin, in addition to the previously reimbursed group of people ages 2-18.
Canadians who rely on insulin are at risk of experiencing severe hypoglycemia, which can cause complications and potentially be fatal. Select continuous glucose monitoring systems, such as Dexcom G7 and Dexcom G6, are equipped with a predictive Urgent Low Soon alert that can warn users up to 20 minutes in advance of a severe hypoglycemic event (< 3.1 mmol/L), prompting the user to take preventative action. This exclusive feature of Dexcom CGM systems can mean the difference between experiencing hypoglycemia or potentially avoiding it altogether.
"Managing diabetes presents unique challenges for Canadians who rely on insulin. While insulin is life-sustaining, determining the appropriate dosage can be challenging without the data provided by continuous glucose monitoring systems," says André Côté, Vice-President and General Manager, Dexcom Canada. "The Government of Saskatchewan’s decision to provide public coverage for Dexcom CGM, regardless of insulin type, is a significant and positive step forward for the diabetes community. This initiative will allow more
Dexcom CGM users also have access to a variety of connected health solutions, including several insulin pumps to automate insulin delivery and digital health apps to personalize care and provide a more holistic view of diabetes management.
Other Dexcom apps, such as the Dexcom Follow app†, allow family members and loved ones to remotely monitor the user’s glucose levels, providing additional security and peace of mind for those who may need it most.
To learn more about Dexcom CGM and public and private coverage options available, please visit dexcom.com.
About Dexcom, Inc.
Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.
Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.
*For a list of compatible devices, visit dexcom.com/compatibility.
† Following requires the Dexcom Follow app and an Internet connection. Followers should always confirm readings on the Dexcom G6 or G7 apps before making treatment decisions. For a list of compatible devices, visit dexcom.com/compatibility.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250401755382/en/
Media Contact:
Cheyenne Freitas
Freitas@veritasinc.com
Source: Dexcom, Inc.
FAQ
What is the new coverage expansion for Dexcom CGM in Saskatchewan?
How many people will benefit from Saskatchewan's Dexcom CGM coverage expansion?
What key feature does Dexcom's CGM system (DXCM) offer for hypoglycemia prevention?
When does the new Dexcom CGM coverage in Saskatchewan take effect?
